25 February 2018
News and Views
Links and Services
The latest issue of Alimentary Pharmacology & Therapeutics evaluates adjuvant therapy for resected biliary tract cancer.
Major adjuvant therapies for biliary tract cancer include fluorouracil, gemcitabine and chemoradi
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors